Australian Rotavirus Surveillance Program: Annual Report, 2018.

This report, from the Australian Rotavirus Surveillance Program and collaborating laboratories Australia-wide, describes the rotavirus genotypes identified in children and adults with acute gastroenteritis during the period 1 January to 31 December 2018. During this period, 690 faecal specimens were referred for rotavirus G- and P- genotype analysis, including 607 samples that were confirmed as rotavirus positive. Of these, 457/607 were wild-type rotavirus strains and 150/607 were identified as rotavirus vaccine-like. Genotype analysis of the 457 wild-type rotavirus samples from both children and adults demonstrated that G3P[8] was the dominant genotype nationally, identified in 52% of samples, followed by G2P[4] (17%). The Australian National Immunisation Program, which previously included both RotaTeq and Rotarix vaccines, changed to Rotarix exclusively on 1 July 2017. Continuous surveillance is needed to identify if the change in vaccination schedule could affect rotavirus genotype distribution and diversity in Australia. © Commonwealth of Australia CC BY-NC-ND.

Citation

Susie Roczo-Farkas, Julie E Bines, Australian Rotavirus Surveillance Group. Australian Rotavirus Surveillance Program: Annual Report, 2018. Communicable diseases intelligence (2018). 2021 Jan 29;45

Mesh Tags

Substances

PMID: 33573534

search → result